AbCellera is a series c plus startup based in Canada. 1 investor tracked.
AbCellera is a startup founded in 2012 based in Canada. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
AbCellera develops AI-powered technology to discover antibodies for therapeutic use, enabling rapid drug discovery and development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.